US Patent Issued to Seoul National University R&DB Foundation on Dec. 2 for "Radioisotope labeled compound for imaging or treatment of prostate cancer" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,294, issued on Dec. 2, was assigned to Seoul National University R&DB Foundation (Seoul, South Korea).

"Radioisotope labeled compound for imaging or treatment of prostate cancer" was invented by Jae Min Jeong (Seoul, South Korea), Nadeem Ahmed Lodhi (Seoul, South Korea) and Yun-sang Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: a derivative in which glutamate-urea-Lysine (GUL) and isonitrile are linked by a linker; a radioisotope labeled compound comprising the derivative; and a pharmaceutical composition for treating and diagnosing prostate cancer, containing the derivative as an active ingr...